Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 6, 2020
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
David Lewis Maintained (TMDX) at Hold with Decreased Target to $16 on, Nov 6th, 2020
David Lewis of Morgan Stanley, Maintained "TransMedics Group, Inc." (TMDX) at Hold with Decreased Target from $18 to $16 on, Nov 6th, 2020.
David has made no other calls on TMDX in the last 4 months.
There are 2 other peers that have a rating on TMDX. Out of the 2 peers that are also analyzing TMDX, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Robert Marcus of "JP Morgan" Downgraded from Buy to Hold and Held Target at $15 on, Thursday, October 8th, 2020
This is the rating of the analyst that currently disagrees with David
- Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $20 on, Thursday, August 6th, 2020
